4.5 Review

Polymeric Drug Delivery of Platinum-Based Anticancer Agents

Journal

JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 98, Issue 7, Pages 2299-2316

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1002/jps.21611

Keywords

polymeric drug delivery systems; polymers; dendrimers; nanoparticles; biodegradable polymers; microparticles; macromolecular drug delivery; macromolecular prodrugs; micelle

Funding

  1. Canada's Research-Based Pharmaceutical Companies (RxD)
  2. Canadian Institutes of Health Research (CIHR)
  3. Natural Sciences and Engineering Research Council of Canada (NSERC) for a Discovery grant

Ask authors/readers for more resources

Platinum-based anticancer agents such as cisplatin and carboplatin are in widespread clinical use but associated with many side effects. Improving the delivery of cytotoxic platinum compounds may lead to reduced side effects and achieve greater efficacy at lower doses. Polymer-based therapeutics have been investigated as potential drug delivery vehicles for platinum-based drugs. Against a background of the chemistry and pharmacology of cytotoxic platinum compounds, this review discusses the formation and properties of platinum-polymer complexes, dendrimers, micelles, and microparticulates. (C) 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:2299-2316, 2009

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available